Takeda Puts Up $247M For Brazilian Drugmaker Multilab

Law360, New York (May 25, 2012, 11:52 AM EDT) -- Japan-based global pharmaceutical and research company Takeda Pharmaceutical Co. Ltd. has agreed to acquire Brazilian drugmaker Multilab Industria e Comercio de Produtos Farmaceuticos Ltda. for roughly $247 million, Takeda said Friday.

The Osaka-based drug manufacturer said it planned to complete the Multilab acquisition later this year. The deal includes a $246.7 million upfront cash payment by Takeda and future milestone payments to Multilab senior management of up to $19.7 million, the buyer said.

Additional financial details of the acquisition were not disclosed. Spokespeople for Takeda and...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.